Aurinia Pharmaceuticals Inc
AUPH15.150USD
-0.180-1.17%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
2.00BMarket Cap
26.33P/E TTM
Aurinia Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
235.13M
33.97%
EPS(YoY)
0.04
107.38%
Analyst Rating
BUY
2026-01-07
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 235.13M, with a year-on-year change of 33.97%.
What is the Earnings Per Share (EPS) of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 0.040, with a year-on-year change of 107.38%.
What is the net income of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its net income was 5.75M, with a year-on-year change of 107.37%.
What is the net margin of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was 2.45%, with a year-on-year change of 105.50%.
What is the gross margin of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 87.99%, with a year-on-year change of -4.30%.
What is the debt-to-asset ratio of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 13.18%, with a year-on-year change of -19.79%.
What is the Return on Equity (ROE) of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was 1.52%, with a year-on-year change of 107.65%.
What is the Return on Assets (ROA) of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was 1.05%, with a year-on-year change of 106.84%.
What is the operating profit of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its operating profit was 18.42M, with a year-on-year change of 120.09%.
What are the current assets of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its current assets were 446.60M, with a year-on-year change of 5.13%.
What are the total assets of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its total assets of Aurinia Pharmaceuticals Inc were 550.64M, with a year-on-year change of 0.47%.
What are the total liabilities of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Aurinia Pharmaceuticals Inc were 173.17M, with a year-on-year change of 1.80%.
What is the total equity of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its total equity of Aurinia Pharmaceuticals Inc was 377.48M, with a year-on-year change of -0.13%.
What is the net operating income of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Aurinia Pharmaceuticals Inc was 5.75M, with a year-on-year change of 107.37%.
What is the net investment of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its net investment of Aurinia Pharmaceuticals Inc was 39.26M, with a year-on-year change of 685.48%.
What is the net financing of Aurinia Pharmaceuticals Inc?
According to Aurinia Pharmaceuticals Inc's FY2024 earnings report, its net financing of Aurinia Pharmaceuticals Inc was -49.09M, with a year-on-year change of -856.96%.
